Enterocutaneous Fistula: Proven Strategies and Updates

Abstract

Management of enterocutaneous fistula represents one of the most protracted and difficult problems in colorectal surgery with substantial morbidity and mortality rates. This article summarizes the current classification systems and successful management protocols, provides an in-depth review of fluid resuscitation, sepsis control, nutrition management, medication management of output quantity, wound care, nonoperative intervention measures, operative timeline, and considerations, and discusses special considerations such as inflammatory bowel disease and enteroatmospheric fistula.

Keywords

enterocutaneous fistula - enteroatmospheric fistula - spontaneous closure - mortality - timeline

• References

• 1 Sitges-Serra A, Jaurrieta E, Sitges-Creus A. Management of postoperative enterocutaneous fistulas: the roles of parenteral nutrition and surgery. Br J Surg 1982; 69 (3) 147-150
• 2 Schein M, Decker GA. Postoperative external alimentary tract fistulas. Am J Surg 1991; 161 (4) 435-438
• 3 Berry SM, Fischer JE. Classification and pathophysiology of enterocutaneous fistulas. SurgClin North Am 1996; 76 (5) 1009-1018
• 4 Lloyd DA, Gabe SM, Windsor AC. Nutrition and management of enterocutaneous fistula. Br J Surg 2006; 93 (9) 1045-1055
• 5 Haffejee AA. Surgical management of high output enterocutaneous fistulae: a 24-year experience. CurrOpinClinNutrMetab Care 2004; 7 (3) 309-316
• 6 Martinez JL, Luque-de-Leon E, Mier J, Blanco-Benavides R, Robledo F. Systematic management of postoperative enterocutaneous fistulas: factors related to outcomes. World J Surg 2008; 32 (3) 436-443 , discussion 444
• 7 Li J, Ren J, Zhu W, Yin L, Han J. Management of enterocutaneous fistulas: 30-year clinical experience. Chin Med J (Engl) 2003; 116 (2) 171-175
• 8 Campos AC, Andrade DF, Campos GM, Matias JE, Coelho JC. A multivariate model to determine prognostic factors in gastrointestinal fistulas. J Am CollSurg 1999; 188 (5) 483-490
• 9 Hollington P, Mawdsley J, Lim W, Gabe SM, Forbes A, Windsor AJ. An 11-year experience of enterocutaneous fistula. Br J Surg 2004; 91 (12) 1646-1651
• 10 Reber HA, Roberts C, Way LW, Dunphy JE. Management of external gastrointestinal fistulas. Ann Surg 1978; 188 (4) 460-467
• 11 Rahbour G, Gabe SM, Ullah MR , et al. Seven-year experience of enterocutaneous fistula with univariate and multivariate analysis of factors associated with healing: development of a validated scoring system. Colorectal Dis 2013; 15 (9) 1162-1170
• 12 Erdmann D, Drye C, Heller L, Wong MS, Levin SL. Abdominal wall defect and enterocutaneous fistula treatment with the vacuum-assisted closure (V.A.C.) system. PlastReconstrSurg 2001; 108 (7) 2066-2068
• 13 Evenson AR, Fischer JE. Current management of enterocutaneous fistula. J GastrointestSurg 2006; 10 (3) 455-464
• 14 Schecter WP. Management of enterocutaneous fistulas. SurgClin North Am 2011; 91 (3) 481-491
• 15 Martinez JL, Luque-de-León E, Ballinas-Oseguera G, Mendez JD, Juárez-Oropeza MA, Román-Ramos R. Factors predictive of recurrence and mortality after surgical repair of enterocutaneous fistula. J GastrointestSurg 2012; 16 (1) 156-163 , discussion 163–164
• 16 Fazio VW, Coutsoftides T, Steiger E. Factors influencing the outcome of treatment of small bowel cutaneous fistula. World J Surg 1983; 7 (4) 481-488
• 17 Lévy E, Frileux P, Cugnenc PH, Honiger J, Ollivier JM, Parc R. High-output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg 1989; 76 (7) 676-679
• 18 Mawdsley JE, Hollington P, Bassett P, Windsor AJ, Forbes A, Gabe SM. An analysis of predictive factors for healing and mortality in patients with enterocutaneous fistulas. Aliment PharmacolTher 2008; 28 (9) 1111-1121
• 19 Bleier JI, Hedrick T. Metabolic support of the enterocutaneous fistula patient. Clin Colon Rectal Surg 2010; 23 (3) 142-148
• 20 Kaushal M, Carlson GL. Management of enterocutaneous fistulas. Clin Colon Rectal Surg 2004; 17 (2) 79-88
• 21 Samad S, Anele C, Akhtar M, Doughan S. Implementing a pro-forma for multidisciplinary management of an enterocutaneous fistula: a case study. Ostomy Wound Manage 2015; 61 (6) 46-52
• 22 Polk TM, Schwab CW. Metabolic and nutritional support of the enterocutaneous fistula patient: a three-phase approach. World J Surg 2012; 36 (3) 524-533
• 23 Schecter WP, Hirshberg A, Chang DS , et al. Enteric fistulas: principles of management. J Am CollSurg 2009; 209 (4) 484-491
• 24 Datta V, Engledow A, Chan S, Forbes A, Cohen CR, Windsor A. The management of enterocutaneous fistula in a regional unit in the United Kingdom: a prospective study. Dis Colon Rectum 2010; 53 (2) 192-199
• 25 Dudrick SJ, Maharaj AR, McKelvey AA. Artificial nutritional support in patients with gastrointestinal fistulas. World J Surg 1999; 23 (6) 570-576
• 26 Irving M, White R, Tresadern J. Three years' experience with an intestinal failure unit. Ann R CollSurgEngl 1985; 67 (1) 2-5
• 27 Dellinger RP, Levy MM, Rhodes A , et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41 (2) 580-637
• 28 Davis KG, Johnson EK. Controversies in the care of the enterocutaneous fistula. SurgClin North Am 2013; 93 (1) 231-250
• 29 Härle K, Lindgren M, Hallböök O. Experience of living with an enterocutaneous fistula. J ClinNurs 2015; 24 (15–16) 2175-2183
• 30 Chapman R, Foran R, Dunphy JE. Management of intestinal fistulas. Am J Surg 1964; 108: 157-164
• 31 Makhdoom ZA, Komar MJ, Still CD. Nutrition and enterocutaneous fistulas. J ClinGastroenterol 2000; 31 (3) 195-204
• 32 Singh R. Evaluation of nutritional status by different parameters and to predict spontaneous closure, morbidity, and mortality in patients with enterocutaneous fistulas: a study of 92 cases. The Internet J Nutrition Wellness 2007; 6 (1) 1-6
• 33 Lu CY, Wu DC, Wu IC , et al. Serum albumin level in the management of postoperative enteric fistula for gastrointestinal cancer patients. J Invest Surg 2008; 21 (1) 25-32
• 34 Lubana PS, Aggarwal G, Aggarwal H, Jain DK. Serum transferrin levels – a predictive marker of spontaneous closure and mortality in patients with enterocutaneous fistulae. Arab J Gastroenterol 2010; 11 (4) 212-214
• 35 Teubner A, Morrison K, Ravishankar HR, Anderson ID, Scott NA, Carlson GL. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula. Br J Surg 2004; 91 (5) 625-631
• 36 Deitel M. Elemental diet and enterocutaneous fistula. World J Surg 1983; 7 (4) 451-454
• 37 Hesse U, Ysebaert D, de Hemptinne B. Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data. Gut 2001; 49 (Suppl. 04) iv11-iv21
• 38 Jenkins SA, Nott DM, Baxter JN. Fluctuations in the secretion of pancreatic enzymes between consecutive doses of octreotide: implications for the management of fistulae. Eur J GastroenterolHepatol 1995; 7 (3) 255-258
• 39 Paran H, Neufeld D, Kaplan O, Klausner J, Freund U. Octreotide for treatment of postoperative alimentary tract fistulas. World J Surg 1995; 19 (3) 430-433 , discussion 433–434
• 40 Sheppard M, Shapiro B, Pimstone B, Kronheim S, Berelowitz M, Gregory M. Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man. J ClinEndocrinolMetab 1979; 48 (1) 50-53
• 41 Jamil M, Ahmed U, Sobia H. Role of somatostatin analogues in the management of enterocutaneous fistulae. J Coll Physicians Surg Pak 2004; 14 (4) 237-240
• 42 Hernández-Aranda JC, Gallo-Chico B, Flores-Ramírez LA, Avalos-Huante R, Magos-Vázquez FJ, Ramírez-Barba EJ. [Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition]. NutrHosp 1996; 11 (4) 226-229
• 43 Torres AJ, Landa JI, Moreno-Azcoita M , et al. Somatostatin in the management of gastrointestinal fistulas. A multicenter trial. Arch Surg 1992; 127 (1) 97-99 , discussion 100
• 44 Scott NA, Finnegan S, Irving MH. Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study. ActaGastroenterolBelg 1993; 56 (3–4) 266-270
• 45 Gayral F, Campion JP, Regimbeau JM , et al; Lanreotide Digestive Fistula. Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae. Ann Surg 2009; 250 (6) 872-877
• 46 Isenmann R, Schielke DJ, Morl FK , et al. Adjuvant therapy with somatostatin iv in postoperative fistulae of the pancreas, gall bladder and small intestine. A multicentre randomised study. Aktuelle Chirurgie 1994; 29: 96-99
• 47 Spiliotis J, Vagenas K, Panagopoulos K, Kalfarentzos F. Treatment of enterocutaneous fistulas with TPN and somatostatin, compared with patients who received TPN only. Br J ClinPract 1990; 44 (12) 616-618
• 48 Sancho JJ, di Costanzo J, Nubiola P , et al. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg 1995; 82 (5) 638-641
• 49 Leandros E, Antonakis PT, Albanopoulos K, Dervenis C, Konstadoulakis MM. Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas. Can J Gastroenterol 2004; 18 (5) 303-306
• 50 Coughlin S, Roth L, Lurati G, Faulhaber M. Somatostatin analogues for the treatment of enterocutaneous fistulas: a systematic review and meta-analysis. World J Surg 2012; 36 (5) 1016-1029
• 51 Rahbour G, Siddiqui MR, Ullah MR, Gabe SM, Warusavitarne J, Vaizey CJ. A meta-analysis of outcomes following use of somatostatin and its analogues for the management of enterocutaneous fistulas. Ann Surg 2012; 256 (6) 946-954
• 52 Galie KL, Whitlow CB. Postoperative enterocutaneous fistula: when to reoperate and how to succeed. Clin Colon Rectal Surg 2006; 19 (4) 237-246
• 53 Brindle CT, Blankenship J. Management of complex abdominal wounds with small bowel fistulae: isolation techniques and exudate control to improve outcomes. J Wound Ostomy Continence Nurs 2009; 36 (4) 396-403
• 54 Wainstein DE, Fernandez E, Gonzalez D, Chara O, Berkowski D. Treatment of high-output enterocutaneous fistulas with a vacuum-compaction device. A ten-year experience. World J Surg 2008; 32 (3) 430-435
• 55 KCI Website. Available at: www.kci1.com . Accessed August 15, 2015
• 56 Medeiros AC, Aires-Neto T, Marchini JS, Brandão-Neto J, Valença DM, Egito ES. Treatment of postoperative enterocutaneous fistulas by high-pressure vacuum with a normal oral diet. Dig Surg 2004; 21 (5–6) 401-405
• 57 Goverman J, Yelon JA, Platz JJ, Singson RC, Turcinovic M. The “Fistula VAC,” a technique for management of enterocutaneous fistulae arising within the open abdomen: report of 5 cases. J Trauma 2006; 60 (2) 428-431 , discussion 431
• 58 Ruiz-López M, Carrasco Campos J, Sánchez Pérez B, González Sánchez A, Fernández Aguilar JL, Bondía Navarro JA. [Negative pressure therapy in wounds with enteric fistulas]. Cir Esp 2009; 86 (1) 29-32
• 59 Cro C, George KJ, Donnelly J, Irwin ST, Gardiner KR. Vacuum assisted closure system in the management of enterocutaneous fistulae. Postgrad Med J 2002; 78 (920) 364-365
• 60 Rao M, Burke D, Finan PJ, Sagar PM. The use of vacuum-assisted closure of abdominal wounds: a word of caution. Colorectal Dis 2007; 9 (3) 266-268
• 61 Fischer JE. A cautionary note: the use of vacuum-assisted closure systems in the treatment of gastrointestinal cutaneous fistula may be associated with higher mortality from subsequent fistula development. Am J Surg 2008; 196 (1) 1-2
• 62 Avalos-González J, Portilla-deBuen E, Leal-Cortés CA , et al. Reduction of the closure time of postoperative enterocutaneous fistulas with fibrin sealant. World J Gastroenterol 2010; 16 (22) 2793-2800
• 63 Rábago LR, Ventosa N, Castro JL, Marco J, Herrera N, Gea F. Endoscopic treatment of postoperative fistulas resistant to conservative management using biological fibrin glue. Endoscopy 2002; 34 (8) 632-638
• 64 Lippert E, Klebl FH, Schweller F , et al. Fibrin glue in the endoscopic treatment of fistulae and anastomotic leakages of the gastrointestinal tract. Int J Colorectal Dis 2011; 26 (3) 303-311
• 65 Winder JS, Pauli EM. Comprehensive management of full-thickness luminal defects: the next frontier of gastrointestinal endoscopy. World J GastrointestEndosc 2015; 7 (8) 758-768
• 66 Lyon JW, Hodde JP, Hucks D, Changkuon DI. First experience with the use of a collagen fistula plug to treat enterocutaneous fistulas. J VascIntervRadiol 2013; 24 (10) 1559-1565
• 67 Lynch AC, Delaney CP, Senagore AJ, Connor JT, Remzi FH, Fazio VW. Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery. Ann Surg 2004; 240 (5) 825-831
• 68 Runström B, Hallböök O, Nyström PO, Sjödahl R, Olaison G. Outcome of 132 consecutive reconstructive operations for intestinal fistula—staged operation without primary anastomosis improved outcome in retrospective analysis. Scand J Surg 2013; 102 (3) 152-157
• 69 Subramaniam MH, Liscum KR, Hirshberg A. The floating stoma: a new technique for controlling exposed fistulae in abdominal trauma. J Trauma 2002; 53 (2) 386-388
• 70 Evans JP, Steinhart AH, Cohen Z, McLeod RS. Home total parenteral nutrition: an alternative to early surgery for complicated inflammatory bowel disease. J GastrointestSurg 2003; 7 (4) 562-566
• 71 Present DH, Rutgeerts P, Targan S , et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340 (18) 1398-1405
• 72 Bor R, Farkas K, Bálint A , et al. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneousfistulizing Crohn's disease—clinical observations from a tertiary Eastern European center. Scand J Gastroenterol 2015; 50 (2) 182-187
• 73 Amiot A, Setakhr V, Seksik P , et al. Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID. Am J Gastroenterol 2014; 109 (9) 1443-1449
• 74 Poritz LS, Rowe WA, Koltun WA. Remicade does not abolish the need for surgery in fistulizing Crohn's disease. Dis Colon Rectum 2002; 45 (6) 771-775